{
    "additionDate": "2020-01-09T18:28:25Z",
    "biotoolsCURIE": "biotools:hep-druginteractions",
    "biotoolsID": "hep-druginteractions",
    "confidence_flag": "low",
    "credit": [
        {
            "email": "krzysimon@gmail.com",
            "name": "Krzysztof Adam Simon",
            "typeEntity": "Person"
        }
    ],
    "description": "Effect of comedication on ombitasvir/paritaprevir/ritonavir \u00b1 dasabuvir \u00b1 ribavirin therapy in chronic hepatitis C.\n\nCookies help us deliver our services. By using our services, you agree to our use of cookies. OK Learn more.\n\nAccess our free, comprehensive and user-friendly drug interaction charts.\n\n||| CORRECT NAME OF TOOL COULD ALSO BE 'OBV', 'OBV PTV', 'PTV', 'RBV'",
    "editPermission": {
        "type": "public"
    },
    "homepage": "http://www.hep-druginteractions.org/",
    "lastUpdate": "2020-01-09T18:28:25Z",
    "name": "hep-druginteractions",
    "owner": "Pub2Tools",
    "publication": [
        {
            "doi": "10.5114/CEH.2019.87634",
            "pmcid": "PMC6781817",
            "pmid": "31598558"
        }
    ],
    "topic": [
        {
            "term": "Drug metabolism",
            "uri": "http://edamontology.org/topic_3375"
        },
        {
            "term": "Virology",
            "uri": "http://edamontology.org/topic_0781"
        },
        {
            "term": "Pharmacology",
            "uri": "http://edamontology.org/topic_0202"
        },
        {
            "term": "Surgery",
            "uri": "http://edamontology.org/topic_3421"
        },
        {
            "term": "Preclinical and clinical studies",
            "uri": "http://edamontology.org/topic_3379"
        }
    ]
}